Aimée H M M Arits

Suggest Changes
Learn More
Clinical and histopathological differentiation between basal cell carcinoma (BCC) and trichoepithelioma (TE) is a frequent problem. Attempts have been made to identify immunohistochemical markers(More)
BACKGROUND Several noninvasive treatment modalities are available for superficial basal cell carcinoma (sBCC). OBJECTIVES This systematic review aims to determine residue, recurrence and(More)
For the treatment of superficial basal cell carcinoma, a prospective, noninferiority, randomized controlled multicenter trial with 601 patients showed that 5% imiquimod cream was superior and(More)
BACKGROUND Noninvasive treatments are frequently used in treatment of superficial basal cell carcinoma (sBCC) because of better cosmetic results, lower costs, and less burden on health care services(More)
BACKGROUND A recent noninferiority randomized controlled trial (RCT) indicated that imiquimod can be considered as superior to methylaminolevulinate photodynamic therapy (MAL-PDT) in the treatment of(More)